Kissito Healthcare International works with academic partners to cure pediatric diarrhea in East Africa

For immediate release: January 25th, 2012.
Contact:
Elizabeth Parsons, Director of International Projects
Tom Clarke, President & CEO

Pediatric diarrhea is one of the leading causes of death among the developing world’s children, killing approximately two million each year. The Rota virus alone is estimated to take the lives of 500,000 children annually. Kissito Healthcare International has been working with the world’s foremost expert on pediatric diarrhea, Dr. Herbert DuPont of the University of Texas-School of Public Health, to put a stop to this epidemic.

Boston University medical students did some fieldwork in Africa on behalf of Kissito where they collected samples of the stools of malnourished children. These samples were then sent to Dr. DuPont’s laboratory which revealed some unfortunate and unexpected findings; 50 of 60 some samples tested positive for E.Coli, Norovirus and Rota virus.

Dr. DuPont had been collaborating with Napo Pharmaceuticals on a drug called Crofelemer that has been shown to dramatically enhance the efficacy of Oral Rehydration Therapy (ORT) in certain populations. He shared his findings with them and as a result, Napo has recently entered into an agreement with the University of Texas and Kissito to conduct clinical trial interventions for Crofelemer in Manafwa District.

The work that Kissito Healthcare International is doing along with the University of Texas, Napo pharmaceuticals, Boston University, and dozens of other affiliates can possibly lead to a major breakthrough in saving the lives of children in under-developed countries, and make a significant positive impact on global health.

About Kissito Healthcare
Founded in 1989, Kissito Healthcare exists solely for the betterment and care of human life. We seek to improve patient outcomes in our domestic and global services through a balanced engagement in academics, research and health care delivery. As a charitable organization, Kissito Healthcare is funded by private and government grants and donations. In nine U.S. facilities, we provide post acute care, chronic disease self –management, long term care, assisted living, Alzheimer/dementia care, specialized respiratory care and employment to more than 800 of the country’s most dedicated and passionate healthcare providers. In our global health initiatives, we provide acute care, primary care, pediatric malnutrition programs, maternal and child health programs, and various research programs related to maternal and child health in the countries of Uganda and Ethiopia. Our global and domestic vision is to develop healthcare delivery systems that lower costs and improve outcomes for the world’s most vulnerable populations where resources are extremely limited.

Our internal culture is intensely guided by our four core values of Integrity, Passion, Excellence, and Respect.